Literature DB >> 15533994

Serum levels of soluble intercellular adhesion molecule-1 and soluble endothelial leukocyte adhesion molecule-1 in Alzheimer's disease.

M Rentzos1, M Michalopoulou, C Nikolaou, C Cambouri, A Rombos, A Dimitrakopoulos, E Kapaki, D Vassilopoulos.   

Abstract

Serum soluble intercellular adhesion molecule-1 (s-ICAM-1) and soluble E-selectin (s-ELAM-1) were evaluated in 25 patients with Alzheimer's disease (AD), 54 patients with noninflammatory neurological diseases (NIND), and 15 control subjects. Patients with AD had a higher s-ICAM-1 level compared with the NIND patients and the control subjects (P< .001 and P< .04, respectively). The presence of high s-ICAM-1 values may be related to immunological processes involved in pathogenetic mechanisms of AD. The not statistically significant values of (s-ELAM-1), a glycoprotein considered an exclusive marker of endothelial activation, compared with the NIND patients and healthy subjects (P< .47 and P< .17, respectively), seem to suggest the neural rather than the endothelial s-ICAM origin in patients with AD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15533994     DOI: 10.1177/0891988704269822

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  12 in total

1.  Potential biomarkers for vascular damage in Alzheimer's disease: thrombomodulin and von Willebrand factor.

Authors:  B B Yavuz; D S Dede; B Yavuz; M Cankurtaran; M Halil; Z Ulger; E S Cankurtaran; K Aytemir; G Kabakci; I C Haznedaroglu; S Ariogul
Journal:  J Nutr Health Aging       Date:  2010-06       Impact factor: 4.075

Review 2.  Neuroimmune nexus of depression and dementia: Shared mechanisms and therapeutic targets.

Authors:  Francis J Herman; Sherry Simkovic; Giulio M Pasinetti
Journal:  Br J Pharmacol       Date:  2019-03-21       Impact factor: 8.739

3.  Cerebrospinal Fluid Proteins as Regulators of Beta-amyloid Aggregation and Toxicity.

Authors:  Kayla M Pate; Regina M Murphy
Journal:  Isr J Chem       Date:  2017-01-18       Impact factor: 3.333

Review 4.  Blood-based biomarkers of microvascular pathology in Alzheimer's disease.

Authors:  Michael Ewers; Michelle M Mielke; Harald Hampel
Journal:  Exp Gerontol       Date:  2009-09-24       Impact factor: 4.032

Review 5.  Biomarkers for cognitive impairment and dementia in elderly people.

Authors:  Joshua A Sonnen; Kathleen S Montine; Joseph F Quinn; Jeffrey A Kaye; John C S Breitner; Thomas J Montine
Journal:  Lancet Neurol       Date:  2008-08       Impact factor: 44.182

Review 6.  Adhesion molecules in CNS disorders: biomarker and therapeutic targets.

Authors:  Qingyi Ma; Sheng Chen; Damon Klebe; John H Zhang; Jiping Tang
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-05-01       Impact factor: 4.388

7.  Clinical Significance of Cerebrovascular Biomarkers and White Matter Tract Integrity in Alzheimer Disease: Clinical correlations With Neurobehavioral Data in Cross-Sectional and After 18 Months Follow-ups.

Authors:  Ming-Kung Wu; Yan-Ting Lu; Chi-Wei Huang; Pin-Hsuan Lin; Nai-Ching Chen; Chun-Chung Lui; Wen-Neng Chang; Chen-Chang Lee; Ya-Ting Chang; Sz-Fan Chen; Chiung-Chih Chang
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

8.  KDM4B histone demethylase and G9a regulate expression of vascular adhesion proteins in cerebral microvessels.

Authors:  Ji-Young Choi; Sang-Sun Yoon; Sang-Eun Kim; Sangmee Ahn Jo
Journal:  Sci Rep       Date:  2017-03-22       Impact factor: 4.379

Review 9.  Dissecting the Crosstalk between Endothelial Mitochondrial Damage, Vascular Inflammation, and Neurodegeneration in Cerebral Amyloid Angiopathy and Alzheimer's Disease.

Authors:  Rebecca M Parodi-Rullán; Sabzali Javadov; Silvia Fossati
Journal:  Cells       Date:  2021-10-27       Impact factor: 6.600

10.  Proteinopathy-induced neuronal senescence: a hypothesis for brain failure in Alzheimer's and other neurodegenerative diseases.

Authors:  Todd E Golde; Victor M Miller
Journal:  Alzheimers Res Ther       Date:  2009-10-12       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.